• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MOLECULAR, INC. VYSIS LSI MDM2 SPECTRUMORANGE, 20 UL PROBE; REAGENTS, SPECIFIC, ANALYTE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MOLECULAR, INC. VYSIS LSI MDM2 SPECTRUMORANGE, 20 UL PROBE; REAGENTS, SPECIFIC, ANALYTE Back to Search Results
Catalog Number 01N15-020
Device Problem Fracture (1260)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/04/2020
Event Type  malfunction  
Manufacturer Narrative
Elevated complaint investigation has been initiated.Note: lot, expiration, udi, manufacture date and pma number have been left blank as this mdr is being submitted on the basis that vysis lsi mdm2 so/cep 12 probe kit (list 01n15-10) is similar to vysis lsi mdm2 spectrumorange, 20 ul probe (list 01n15-020) sold in the united states.Ticket does not reference a us list 01n15-020 lot number.
 
Event Description
The customer received a vysis mdm2/cep12 fish probe kit and found the vial of the probe was shattered upon opening the package.The customer examined the outer package and found there was a folded wrinkle on the side of product package therefore suspecting that the package may have been pressed during transportation.The primary and secondary distributor claimed neither did they open the probe package nor notice signs of damage.The customer requested a replacement.There was no injury associated with the event.The user was wearing latex gloves when handling and opening the package.The customer noticed the folding in the packaging only after opening the kit when asked to check if there was damage on the package.The package folding was not noticeable prior to opening.This event did not involve a patient as it was identified by the user.This incident is being repoted to fda because the incident occurred in (b)(6) using the vysis lsi mdm2 so/cep 12 probe kit, list number 01n15-10, which is the same/ similar to the vysis lsi mdm2 spectrumorange, 20 ul probe, list number 01n15-020, which is registered with fda as an analyte specific reagent.
 
Manufacturer Narrative
Investigation into this complaint included an evaluation of the quality data review (device history record (dhr) review and capa review), abbott molecular (am) retain inspection, customer image review and complaint history review.The results of the investigation are summarized as follows: quality data review; device history record / batch record review.No issues or errors were identified.The product under investigation met specifications at the time of release.Capa / non-conformance review: each unique lot is individually qualified at kit lot manufacturing for the materials in question; therefore, the search was lot specific.All related material in question was accounted for in the search criteria.Any resulting capa were then reviewed to determine relevance to this investigation.No related capa were identified.Product/system/instrument evaluation: retain / file sample evaluation: an inspection using the am retain sample (quantity (qty.) 1) from the same lot of material in question was performed to determine if products had any obvious identifiable damage, including broken probe bottle.No damage was identified.Return sample evaluation: the customer's sample was not available for this investigation, however the customer provided images were reviewed.Complaint history review: a search for complaints reporting damaged in reference to vysis lsi mdm2 so/cep 12 sgn fish probe kit (lot# 502252) and probe used (lot# 501637) to manufacture the kit in question identified no additional complaints.Based on the results of the investigation elements, no product deficiency has been identified for vysis lsi mdm2 so/cep 12 sgn fish probe kit: list # 01n15-010/lot# 502252.The customer reported the event post shipment and handling.There have been no other reported complaints related to the lot of material in question and no other element of the investigation suggests a systemic issue.Correction: on initial report, date received by manufacturer stated 07-jun-2020, but should have been 05-jun-2020.Quality assurance was made aware of this updated information on 26-jun-2020, which will serve as the date received by manufacturer for this final report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VYSIS LSI MDM2 SPECTRUMORANGE, 20 UL PROBE
Type of Device
REAGENTS, SPECIFIC, ANALYTE
Manufacturer (Section D)
ABBOTT MOLECULAR, INC.
1300 e. touhy ave.
des plaines, il
MDR Report Key10197662
MDR Text Key230493599
Report Number3005248192-2020-00024
Device Sequence Number1
Product Code MVU
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 07/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Catalogue Number01N15-020
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 06/07/2020
Initial Date FDA Received06/25/2020
Supplement Dates Manufacturer Received06/26/2020
Supplement Dates FDA Received07/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-